Due to a high demand, APAAACI & APAPARI 2018 is pleased to announce the EXTENSION of POSTER SUBMISSION* until 24 August 2018. If you have any new research, here is your chance to get your work out there, get some facetime with the leading lights in your field, and get the recognition you deserve.
*Remarks: Abstracts may be submitted for poster presentation only. The Abstract Submitter must warrant and represent that he/she is the sole owner or has the rights of all the information and content provided to APAAACI & APAPARI 2018. The abstracts submitted should not infringe any third party rights including, but not limited to, intellectual property rights. The poster submission must be an original work and has never been submitted to other events or published before. Accepted poster presentations will not be published on the scientific program proceedings.
Joint Congress of Asia Pacific Association of Allergy, Asthma and Clinical Immunology (APAAACI) and Asia Pacific Association of Pediatric Allergy, Respirology& Immunology (APAPARI) 2018 will be held on 11 – 14 October 2018 at the Centara Grand & Bangkok Convention Centre at CentralWorld. The theme of the Congress is “Novel Therapies, Prevention and Integrated Action: Towards Improved Patient Care” and with this theme in mind the Local Organizing Committee (LOC) aims to create a platform for the exchange and progress of knowledge on allergy, asthma, and clinical immunology in this region. Hence, the Joint Congress of APAAACI and APAPARI 2018 Scientific Committee now wishes to invite abstracts for oral and poster presentations.
Please carefully read the Abstract Guideline below before submitting an abstract. Abstracts can only be submitted electronically through official Congress website. Abstract sent by post, fax or email WILL NOT BE ACCEPTED.
|Open for abstract submission||: 16 January 2018|
|Extended Poster Submission Deadline||: 24 August 2018|
Structure of the Abstract
In order to make the abstract as informative as possible, please provide:
It is inadequate to state “The results will be discussed” or “The data will be presented”.
We kindly ask you to subtitle the paragraphs in bold format in the following order: Background, Method, Results, and Conclusions.
Affiliations should include department, institute, town and country. Where there are multiple affiliations, each should be listed as a separate paragraph. Each institute should appear in the order used against the author names and show the appropriate superscript number, e.g.:
1 Department, University, Town, State, Zip code, Malaysia
2 University, Town, State, Postcode, Malaysia
3 Company, Town, State, Malaysia, Postcode
** Please note! If affiliations are not listed as above you will not be published! **
Consent to Publish
Should your abstract contain identifiable information about a patient, we ask all consent is received before submitting your abstract. Please check the box if you have received consent to publish or if you do not need consent to publish.
Changes to abstracts are accepted only until the submission deadline by using the abstract submission website. After 30 June 2018, no changes or revisions will be allowed.
Notification of Acceptance
Notification of acceptance/rejection will be emailed. The Presenting Author will receive all correspondence regarding the abstract status, presentation type, date and time, via the email that is provided in the abstract submission.
Publication of Abstracts
Accepted Abstract Authors will have their abstract published online at the official Congress website
Attendance of Presenters
Joint Congress of APAAACI and APAPARI cannot guarantee that Presenting Authors who do not show up during the session will be accepted for abstract presentations at future meetings.
Registration and Payment
The Presenting Author must register for the Congress as delegate and pay the fee before 31 August 2018. Abstracts will be automatically withdrawn if the Presenting Author is not registered.
The Presenting Author of an accepted abstract is allowed to register with Early Bird Fee until 31 August 2018.